BlackRock BTZ Insider Filing: 824.31 Performance Rights, Cash-Settled
Rhea-AI Filing Summary
James Phillip Holloman, a director of BlackRock Credit Allocation Income Trust (BTZ), reported a non-derivative change and a derivative grant on 10/01/2025. He received 824.31 Performance Rights under the BlackRock Deferred Compensation Plan; each right converts into the cash value of one share of BTZ and the award is to be settled 100% in cash at the chosen deferral date. The filing shows a price of $11.03 and indicates beneficial ownership of 16,837.46 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Positive
- 824.31 Performance Rights awarded to a director, showing continued executive alignment with BTZ
- Award is to be settled 100% in cash, so there is no immediate share dilution from these rights
Negative
- None.
Insights
Director received performance rights settled in cash, increasing disclosed beneficial holdings.
The filing documents a grant of 824.31 Performance Rights under the BlackRock Deferred Compensation Plan, awarded to director James Phillip Holloman on 10/01/2025. Each right converts to the cash value of one share, so the award does not create immediate new shares but increases the director's economic interest tied to BTZ's share value.
This award is to be settled 100% in cash, which is important for shareholders because it avoids share dilution from settlement in stock; the report lists a reference price of $11.03 and post-transaction beneficial ownership of 16,837.46 shares.
FAQ
What did BTZ director James Phillip Holloman report on Form 4?
Are the Performance Rights for BTZ settled in stock or cash?
What is the reported price and post-transaction beneficial ownership?
When was the Form 4 filed and who signed it?
What plan governs the Performance Rights granted to Holloman?